Failure of Romidepsin to Treat Relapsed/Refractory Peripheral T-Cell Lymphoma in Children: A Single-center Experience

J Pediatr Hematol Oncol. 2021 Jul 1;43(5):e745-e748. doi: 10.1097/MPH.0000000000001824.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antibiotics, Antineoplastic / therapeutic use*
  • Child
  • Child, Preschool
  • Depsipeptides / therapeutic use*
  • Female
  • Histone Deacetylase 1 / antagonists & inhibitors
  • Histone Deacetylase Inhibitors / therapeutic use*
  • Humans
  • Lymphoma, T-Cell, Peripheral / drug therapy*
  • Male
  • Neoplasm Recurrence, Local / drug therapy*
  • Treatment Failure

Substances

  • Antibiotics, Antineoplastic
  • Depsipeptides
  • Histone Deacetylase Inhibitors
  • romidepsin
  • Histone Deacetylase 1